Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination With Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines
Advances in Clinical and Experimental Medicine - Poland
doi 10.17219/acem/32934
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Wroclaw Medical University